The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and only twice-a-year, 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis (MS).
FDA approves injectable Ocrevus Zunovo for relapsing, progressive multiple sclerosis retrieved 26 September 2024 from https://medicalxpress.com/news/2024-09-fda-ocrevus-zunovo-relapsing-multiple.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA expands approval of Omnipod 5 insulin delivery system to include patients with type 2 diabetesOn August 26, the U.S. Food and Drug Administration approved the Insulet Omnipod 5 insulin delivery system for patients with type 2 diabetes. It is the first such system for use by people with the more prevalent form of the disease.
Read more »
FDA set to regulate arsenic and cadmium in baby foodRice and spinach are staples for babies' and young children's diets, but toxic metals and metalloids found in those foods can cause severe health impacts.
Read more »
FDA set to regulate arsenic and cadmium in baby foodRice and spinach are staples for babies' and young children's diets, but toxic metals and metalloids found in those foods can cause severe health impacts.
Read more »
FDA to investigate safety of toxic metals in tamponsThe U.S. Food and Drug Administration announced Tuesday that it will launch an independent review into any possible effects of toxic metals found in tampons.
Read more »
Apple AirPods Pro 2 can be sold as hearing aids, says FDAYou gotta admit, that speaks volumes for Cupertino
Read more »
FDA approves Tremfya for ulcerative colitisThe U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.
Read more »